PLG and lung adenocarcinoma: A plasmin inhibitor, EACA (Epsilon-aminocaproic acid44), ably blocked HAI-2 knockdown-induced plasmin activity (Fig. 4i), the lung adenocarcinoma cell migration and invasion (Figs. 4j, k; Supplementary Figure S6).